ALBANY, N.Y. (NEWS10) — New York’s Attorney General is questioning a pharmaceutical company over its price increase of a treatment for a deadly infection.
Eric Schneiderman is looking into whether ‘Turing Pharmaceuticals’ is trying to prevent generic versions of Daraprim from being produced.
Daraprim is used to treat parasitic infections, as well as patients with AIDS and cancer.
Shortly after acquiring rights to the drug, Turing raised its price from just over $13 a tablet to $750 per pill.
Turing recently pledged to lower the price of Daraprim after protests, but hasn’t done it yet.